In 2022 the company made a revenue of $33.19 M an increase over the years 2021 revenue that were of $18.81 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | -100% |
2022 | $33.19 M | 76.41% |
2021 | $18.81 M | 22.16% |
2020 | $15.4 M | -24.83% |
2019 | $20.49 M | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | N/A | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | N/A | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | N/A | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | N/A | Jersey |